Myelodysplastic Syndrome Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Myelodysplastic Syndrome Clinical Trials Overview
The Myelodysplastic Syndrome Clinical Trials research report provides an overview of the top-line data relating to the clinical trials on Myelodysplastic syndrome. Furthermore, gain an overview of trial numbers across the globe with detailed coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type. The report also includes the names of prominent sponsors involved with conducting the Myelodysplastic syndrome clinical trials.
Key Regions | · Asia-Pacific
· Europe · North America · Middle East and Africa · South and Central America |
Key Countries | · The US
· China · Germany · France · Italy · Japan · The UK · Spain · Canada · Netherlands |
Key Sponsor Types | · Company
· Institution · Government |
Leading Sponsors | · Bristol-Myers Squibb Co
· Novartis AG · Sanofi · Pfizer Inc · Johnson & Johnson · Merck & Co Inc · Others |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Myelodysplastic Syndrome Clinical Trials Segmentation by Regions and Countries
North America led the Myelodysplastic syndrome clinical trials landscape with more than 50% of the clinical trials conducted there as of September 2023.
The key regions considered for Myelodysplastic syndrome clinical trials analysis are Asia-Pacific, Europe, North America, Middle East and Africa, and South and Central America.
In a country-wise analysis, as of September 2023, the US accounted for the highest number of Myelodysplastic syndrome clinical trials, followed by China and Germany.
E7 countries: Among the E7 countries, Russia has the highest proportion of Myelodysplastic syndrome to Oncology clinical trials as of September 2023. The E7 is group of China, India, Russia, Turkey, Brazil, Mexico, and Indonesia.
G7 countries: Among the G7 countries, the US has the highest proportion of Myelodysplastic syndrome to Oncology clinical trials as of September 2023. The G7 is a group of United States, United Kingdom, Germany, Canada, Japan, France, and Italy.
Myelodysplastic Syndrome Clinical Trials Analysis by Regions, 2023 (%)
Buy Full Report for More Regional Insights into the Myelodysplastic Syndrome Clinical Trials
Myelodysplastic Syndrome Clinical Trials Segmentation by Sponsor Types
The key sponsor types for Myelodysplastic Syndrome clinical trials are company, institution, and the government. As of September 2023, the institution sponsor type dominated the Myelodysplastic syndrome clinical trials share, followed by company.
Myelodysplastic Syndrome Clinical Trials Analysis by Sponsor Type, 2023 (%)
Buy Full Report for More Sponsor Type Insights into Myelodysplastic Syndrome Clinical Trials
Myelodysplastic Syndrome Clinical Trials - Competitive Landscape
Some of the leading sponsors for Myelodysplastic syndrome clinical trials are:
- Bristol-Myers Squibb Co
- Novartis AG
- Sanofi
- Pfizer Inc
- Johnson & Johnson
- Merck & Co Inc
In 2023, Bristol-Myers Squibb Co conducted the highest number of Myelodysplastic syndrome clinical trials. It was followed by Novartis AG.
Myelodysplastic Syndrome Clinical Trials Analysis by Sponsors, 2023 (%)
Buy Full Report to Know More About the Leading Players of Myelodysplastic Syndrome Clinical Trials Download a Free Sample Report
Scope
- The report provides a snapshot of the global clinical trials landscape.
- The report provides top-level data related to the clinical trials by region, country (G7 & E7), trial status, trial phase, sponsor type, and endpoint status.
- The report reviews the top companies involved and enlists all trials (trial title, phase, and status) pertaining to the company.
- The report provides all the unaccomplished trials (terminated, suspended, and withdrawn) with a reason for accomplishment.
- The report provides enrollment trends for the past five years.
- The report provides the latest news for the past three months.
Reasons to Buy
- Assists in formulating key business strategies concerning investment.
- Helps identify prominent locations for conducting clinical trials which saves time and cost.
- Provides top-level analysis of the global clinical trials market which helps identify key business opportunities.
- Supports understanding of trial count and enrollment trends by country in the global therapeutics market.
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended, or withdrawn) trials.
- Facilitates clinical trial assessment of the indication on a global, regional, and country level.
Novartis AG
Sanofi
Pfizer Inc
Johnson & Johnson
Merck & Co Inc
Otsuka Holdings Co Ltd
Takeda Pharmaceutical Co Ltd
Amgen Inc
F. Hoffmann-La Roche Ltd
Table of Contents
Table
Figures
Frequently asked questions
-
Which region accounted for the highest number of Myelodysplastic syndrome clinical trials?
North America accounted for the highest number of Myelodysplastic syndrome clinical trials as of September 2023.
-
Which country conducted the highest number of Myelodysplastic syndrome clinical trials?
The US conducted the highest number of Myelodysplastic syndrome clinical trials as of September 2023.
-
Which sponsor type was the most prominent in the Myelodysplastic syndrome clinical trials?
Institution was the most prominent sponsor type for Myelodysplastic syndrome clinical trials.
-
Who are the leading sponsors of Myelodysplastic syndrome clinical trials?
Some of the leading sponsors of Myelodysplastic syndrome clinical trials are Bristol-Myers Squibb Co, Novartis AG, Sanofi, Pfizer Inc, Johnson & Johnson, and Merck & Co Inc, among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.